TMO - Thermo Fisher Scientific
524.05
| Index: | S&P 500 | P/E: | 32.86 | EPS (ttm): | 15.95 | Insider Own: | 0.13% | Shs Outstand: | 382.50M | Perf Week: | -0.54% |
| Market Cap: | 203.30B | Forward P/E: | 22.39 | EPS next Y: | 23.40 | Insider Trans: | -22.95% | Shs Float: | 381.99M | Perf Month: | 2.19% |
| Income(ttm): | 6.14B | PEG: | 5.15 | EPS next Q: | 5.95 | Inst Own: | 90.13% | Short Float: | 0.93% | Perf Quarter: | -14.14% |
| Revenue(ttm): | 42.37B | P/S: | 4.80 | EPS this Y: | 0.70% | Inst Trans: | -0.86% | Short Ratio: | 2.07 | Perf Half Y: | -7.40% |
| Book/sh: | 128.08 | P/B: | 4.09 | EPS next Y: | 7.85% | ROA: | 6.22% | Short Interest: | 3.54M | Perf Year: | 0.89% |
| Cash/sh: | 17.16 | P/C: | 30.54 | EPS next 5Y: | 6.38% | ROE: | 13.01% | 52W Range: | 493.30 - 627.88 | Perf YTD: | -1.27% |
| Dividend Est.: | 1.56 (0.30%) | P/FCF: | 26.15 | EPS past 5Y: | 16.37% | ROI: | 7.65% | 52W High: | -16.54% | Beta: | 0.77 |
| Dividend TTM: | 1.56 (0.30%) | Quick Ratio: | 1.26 | Sales past 5Y: | 12.53% | Gross Margin: | 39.76% | 52W Low: | 6.23% | ATR (14): | 11.08 |
| Dividend Ex-Date: | Dec 13, 2024 | Current Ratio: | 1.63 | EPS Y/Y TTM: | 4.36% | Oper. Margin: | 17.41% | RSI (14): | 45.06 | Volatility: | 2.34% 1.91% |
| Employees: | 122000 | Debt/Eq: | 0.72 | Sales Y/Y TTM: | -2.42% | Profit Margin: | 14.48% | Recom: | 1.47 | Target Price: | 657.08 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.64 | EPS Q/Q: | -3.97% | Payout: | 9.06% | Rel Volume: | 1.58 | Prev Close: | 516.69 |
| Sales Surprise: | -0.34% | EPS Surprise: | 0.72% | Sales Q/Q: | 0.23% | Earnings: | Oct 23 BMO | Avg Volume: | 1.71M | Price: | 524.05 |
| SMA20: | -0.28% | SMA50: | -3.77% | SMA200: | -8.69% | Undervalued: 25.38% | Volume: | 2,713,538 | Change: | 1.42% | |
Graham Classic formula value: 304.5
(P/E=8 * 1g) Min value: 205.96
(current P/E * 2g) Max value: 653.39
Average value: 387.95
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.